These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 28263995)
1. Metabolic activity, urease production, antibiotic resistance and virulence in dual species biofilms of Staphylococcus epidermidis and Staphylococcus aureus. Vandecandelaere I; Van Nieuwerburgh F; Deforce D; Coenye T PLoS One; 2017; 12(3):e0172700. PubMed ID: 28263995 [TBL] [Abstract][Full Text] [Related]
2. Effect of Antimicrobial and Physical Treatments on Growth of Multispecies Staphylococcal Biofilms. Stewart EJ; Payne DE; Ma TM; VanEpps JS; Boles BR; Younger JG; Solomon MJ Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411222 [TBL] [Abstract][Full Text] [Related]
3. Protease production by Staphylococcus epidermidis and its effect on Staphylococcus aureus biofilms. Vandecandelaere I; Depuydt P; Nelis HJ; Coenye T Pathog Dis; 2014 Apr; 70(3):321-31. PubMed ID: 24436195 [TBL] [Abstract][Full Text] [Related]
4. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. Singh R; Ray P; Das A; Sharma M J Antimicrob Chemother; 2010 Sep; 65(9):1955-8. PubMed ID: 20615927 [TBL] [Abstract][Full Text] [Related]
5. Small Molecules Produced by Commensal Staphylococcus epidermidis Disrupt Formation of Biofilms by Staphylococcus aureus. Glatthardt T; Campos JCM; Chamon RC; de Sá Coimbra TF; Rocha GA; de Melo MAF; Parente TE; Lobo LA; Antunes LCM; Dos Santos KRN; Ferreira RBR Appl Environ Microbiol; 2020 Feb; 86(5):. PubMed ID: 31862721 [TBL] [Abstract][Full Text] [Related]
6. Phenotypic and genotypic characterization of Staphylococci causing breast peri-implant infections in oncologic patients. Barbieri R; Pesce M; Franchelli S; Baldelli I; De Maria A; Marchese A BMC Microbiol; 2015 Feb; 15(1):26. PubMed ID: 25888077 [TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections. Molina-Manso D; del Prado G; Ortiz-Pérez A; Manrubia-Cobo M; Gómez-Barrena E; Cordero-Ampuero J; Esteban J Int J Antimicrob Agents; 2013 Jun; 41(6):521-3. PubMed ID: 23611308 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections. Fernández J; Greenwood-Quaintance KE; Patel R Diagn Microbiol Infect Dis; 2016 Aug; 85(4):449-51. PubMed ID: 27241369 [TBL] [Abstract][Full Text] [Related]
9. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains. Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759 [TBL] [Abstract][Full Text] [Related]
11. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667 [TBL] [Abstract][Full Text] [Related]
12. In vivo activity of anprocide alone, and in vitro activity in combination with conventional antibiotics against Staphylococcus aureus and Staphylococcus epidermidis biofilms. Pettit RK; Weber CA; Lawrence SB; Pettit GR; Kean MJ; Cage GD J Med Microbiol; 2009 Sep; 58(Pt 9):1203-1206. PubMed ID: 19528175 [TBL] [Abstract][Full Text] [Related]
13. Does Extracellular DNA Production Vary in Staphylococcal Biofilms Isolated From Infected Implants versus Controls? Zatorska B; Groger M; Moser D; Diab-Elschahawi M; Lusignani LS; Presterl E Clin Orthop Relat Res; 2017 Aug; 475(8):2105-2113. PubMed ID: 28194715 [TBL] [Abstract][Full Text] [Related]
14. Genotypes, antibiotic resistance, and virulence factors of staphylococci from ready-to-eat food. Podkowik M; Bystroń J; Bania J Foodborne Pathog Dis; 2012 Jan; 9(1):91-3. PubMed ID: 21988402 [TBL] [Abstract][Full Text] [Related]
15. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms. Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828 [TBL] [Abstract][Full Text] [Related]
16. Erythromycin resistance features and biofilm formation affected by subinhibitory erythromycin in clinical isolates of Staphylococcus epidermidis. He HJ; Sun FJ; Wang Q; Liu Y; Xiong LR; Xia PY J Microbiol Immunol Infect; 2016 Feb; 49(1):33-40. PubMed ID: 24768213 [TBL] [Abstract][Full Text] [Related]
17. Calcium-chelating alizarin and other anthraquinones inhibit biofilm formation and the hemolytic activity of Staphylococcus aureus. Lee JH; Kim YG; Yong Ryu S; Lee J Sci Rep; 2016 Jan; 6():19267. PubMed ID: 26763935 [TBL] [Abstract][Full Text] [Related]
18. Biofilm-forming capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from ocular infections. Hou W; Sun X; Wang Z; Zhang Y Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5624-31. PubMed ID: 22736609 [TBL] [Abstract][Full Text] [Related]
19. Patient-specific effects of soluble factors from Staphylococcus aureus and Staphylococcus epidermidis biofilms on osteogenic differentiation of primary human osteoblasts. Tübel J; Maier E; Jegen M; Marthen C; Obermeier A; Haug AT; Schneider J; Burgkart R Sci Rep; 2021 Aug; 11(1):17282. PubMed ID: 34446785 [TBL] [Abstract][Full Text] [Related]
20. Effects of demethylfruticuline A and fruticuline A from Salvia corrugata Vahl. on biofilm production in vitro by multiresistant strains of Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis. Schito AM; Piatti G; Stauder M; Bisio A; Giacomelli E; Romussi G; Pruzzo C Int J Antimicrob Agents; 2011 Feb; 37(2):129-34. PubMed ID: 21163629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]